Q1 EPS Estimates for agilon health Lifted by Leerink Partnrs

agilon health, inc. (NYSE:AGL) – Equities research analysts at Leerink Partnrs lifted their Q1 2026 earnings per share (EPS) estimates for agilon health in a note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.01 for the quarter, up from their previous forecast of ($0.01). The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health’s FY2028 earnings at $0.01 EPS.

Several other analysts also recently issued reports on AGL. Cowen reissued a “hold” rating on shares of agilon health in a report on Tuesday, April 15th. Barclays raised their target price on agilon health from $2.00 to $3.00 and gave the company an “underweight” rating in a research note on Thursday. Stifel Nicolaus increased their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday, February 26th. Sanford C. Bernstein raised shares of agilon health from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.89.

agilon health Stock Performance

Shares of NYSE AGL opened at $2.87 on Friday. The stock has a market capitalization of $1.19 billion, a P/E ratio of -3.05 and a beta of 0.38. The firm’s 50-day moving average price is $4.27 and its two-hundred day moving average price is $3.19. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the prior year, the company earned ($0.02) earnings per share. The firm’s revenue was down 4.5% compared to the same quarter last year.

Institutional Trading of agilon health

Several institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC raised its position in agilon health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after acquiring an additional 6,783 shares in the last quarter. Oak Thistle LLC acquired a new position in shares of agilon health in the 4th quarter worth approximately $25,000. Ieq Capital LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $26,000. Signaturefd LLC lifted its stake in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Finally, Ridgecrest Wealth Partners LLC bought a new stake in agilon health during the first quarter worth approximately $65,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.